Altria Group, Inc. (MO) Stock Price & How to Invest

Altria Group is one of the largest tobacco companies in the United States, best known for the Marlboro cigarette brand sold through its Philip Morris USA subsidiary. Altria's core business is selling combustible cigarettes in the US market, where Marlboro holds a dominant share. Despite long-term declines in cigarette smoking rates, Altria has historically sustained revenue and profit by raising prices faster than volumes fall, a pricing power rooted in brand loyalty and an addictive product. The company also owns smokeless and oral tobacco brands (Copenhagen, Skoal, and the on! nicotine pouch line), the NJOY e-vapor brand, and stakes in other businesses. Altria is structured as a high-cash-return company: it pays one of the largest dividend yields among large-cap US stocks and returns substantial cash to shareholders through dividends and buybacks. The central long-term challenge is the secular decline of cigarette smoking and the company's mixed track record in transitioning to reduced-risk products. Founded in its modern form after the Philip Morris International spin-off in 2008 and headquartered in Richmond, Virginia, Altria is a defensive, high-yield consumer-staples stock.

The central risk is the secular decline in US cigarette smoking, which steadily shrinks Altria's core volumes; at some point pricing may not fully offset falling volumes. Regulatory threats are severe and ongoing: potential FDA menthol bans, proposals to cap nicotine levels, flavored-product restrictions, and excise-tax increases could all impair the business. Altria's transition to reduced-risk products has been uneven, including a large write-down on its prior Juul investment. Litigation and reputational risk are persistent. The high payout limits reinvestment flexibility, and illicit and competing nicotine products (including disposable vapes) erode share. ESG exclusions limit the investor base. The stock can stagnate when volume declines accelerate faster than pricing can offset.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Altria Group, Inc.'s investor relations page or your broker.

• Revenue (TTM): ~$20 billion (net of excise taxes; ~$24 billion gross)
• Operating margin: ~55% (high, reflecting cigarette pricing power)
• Net income (TTM): ~$8-11 billion (varies with one-time items)
• EPS (adjusted): ~$5.20
• P/E (TTM): ~11x on adjusted earnings
• Dividend yield: ~7%, a Dividend King with decades of increases
• Payout ratio: ~80% of adjusted earnings (target)
• US cigarette share: Marlboro leads with roughly 40%+ retail share

Altria trades at a low earnings multiple and a very high dividend yield, reflecting the market's view of declining cigarette volumes and heavy regulatory risk against durable pricing power and cash generation. The low multiple is the trade-off for an income stream most investors expect to grow slowly at best. ESG exclusions and secular concerns keep the valuation compressed.

If you want MO exposure as part of a larger bundle rather than directly, these ETFs hold it meaningfully. Weights are approximate and refresh quarterly.

There are three common ways to get MO exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it (DIV, SPHD, DVY), which spreads the position across many companies. Or build it into a focused thematic basket, so MO sits alongside other stocks that express the same thesis.

Walnut takes the basket route. Describe a thesis where MO fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

Altria (MO) is a high-yield tobacco cash cow whose Marlboro pricing power funds one of the largest large-cap dividends, traded at a low multiple because of declining US cigarette volumes, heavy regulatory risk, and ESG exclusions. In a portfolio it behaves as a defensive, low-beta income holding whose central tension is whether pricing keeps offsetting volume declines, not the economic cycle.

Whether MO is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is MO a buy?, and where the stock could go from here in the MO stock forecast.

For income investors, whether MO pays a dividend and how the payout looks is covered in does MO pay a dividend?